Results 91 to 100 of about 4,024 (132)

Unveiling primary Hyperoxaluria type 1: a fortuitous discovery through bone marrow biopsy. [PDF]

Oxf Med Case Reports
Aaboudech TY, Znati K, Jahid A, Sassi S, Driouich S, Zouaidia F, Bernoussi Z.   +6 more
europepmc   +1 more source

Cutting through the stones: Unlocking therapeutic potential with gene editing tools for primary hyperoxaluria type 1. [PDF]

Mol Ther
Schneller J, Du W, Ding H.
europepmc   +1 more source

[Primary hyperoxaluria].

Srpski arhiv za celokupno lekarstvo, 1979
S, Berger, P, Spasić, M, Vacić, G, Tasić, M, Mihailović   +4 more
openaire   +1 more source

Efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria: A systematic review and meta-analysis of randomized controlled trials. [PDF]

Indian J Urol
Khan U, Mubariz M, Rezq H, Mahmoud A, Moiz Nasir M, Ul Ain N, Bazai UK, Khan MZ, Abuelazm M.   +8 more
europepmc   +1 more source

Correction: Lumasiran: A Review in Primary Hyperoxaluria Type 1. [PDF]

Drugs
Kang C.
europepmc   +1 more source

Synthesis and hLDHA Inhibitory Activity of New Stiripentol-Related Compounds of Potential Use in Primary Hyperoxaluria. [PDF]

Int J Mol Sci
Rico-Molina M, Ortega-Vidal J, Molina-Canteras J, Cobo J, Altarejos J, Salido S.   +5 more
europepmc   +1 more source

Human glyoxylate metabolism revisited: New insights pointing to multi-organ involvement with implications for siRNA-based therapies in primary hyperoxaluria. [PDF]

J Inherit Metab Dis
Wanders RJA, Groothoff JW, Deesker LJ, Salido E, Garrelfs SF.   +4 more
europepmc   +1 more source

Efficient and safe in vivo treatment of primary hyperoxaluria type 1 via LNP-CRISPR-Cas9-mediated glycolate oxidase disruption. [PDF]

Mol Ther
Jiang Y, Chen S, Hsiao S, Zhang H, Xie D, Wang ZJ, Ren W, Liu M, Liao J, Wu Y.   +9 more
europepmc   +1 more source